Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Translational Oncology|March 15, 2021
Opinion: miRNAs - The new wave of molecular cancer therapeuticsHernando Lopez-Bertoni, John LaterraMolecular & Cellular Oncology|June 17, 2016
The cancer stem cell phenotype: You can't win until you learn how to lose itHernando Lopez-Bertoni, John LaterraFrontiers in Genetics|May 22, 2024
Cellular diversity through space and time: adding new dimensions to GBM therapeutic developmentAmanda L Johnson, Hernando Lopez-BertoniBiology and Medicine (Aligarh)|May 10, 2016
Cancer Stem Cells: Dynamic Entities in an Ever-Evolving ParadigmHernando Lopez-Bertoni, Yunqing Li, John LaterraFrontiers in Oncology|October 10, 2022
Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunitiesAmanda L Johnson, John Laterra, Hernando Lopez-BertoniToxicology and Applied Pharmacology|July 7, 2019
TET1 regulates DNA repair in human glial cellsKatherine J Kuhns, Hernando Lopez-Bertoni, Jonathan B Coulter, et al.Plos One|March 3, 2012
Pivotal role of inosine triphosphate pyrophosphatase in maintaining genome stability and the prevention of apoptosis in human cellsMiriam Rose Menezes, Irina S-R Waisertreiger, Hernando Lopez-Bertoni, et al.Biorxiv : the Preprint Server for Biology|February 23, 2026
High Mannose Content of Mesenchymal Glioblastoma Correlates with Hydroxyl Proton Transfer-Weighted (HPTw) MRI as Non-Invasive Biomarker for Tumor AggressivenessBehnaz Ghaemi, Hernando Lopez-Bertoni, Shreyas Kuddannaya, et al.Science Advances|May 13, 2026
High mannose content of mesenchymal glioblastoma correlates with hydroxyl proton transfer-weighted (HPTw) MRI as noninvasive biomarker of tumor aggressivenessBehnaz Ghaemi, Hernando Lopez-Bertoni, Shreyas Kuddannaya, et al.Epigenetics|August 1, 2017
TET1 deficiency attenuates the DNA damage response and promotes resistance to DNA damaging agentsJonathan B Coulter, Hernando Lopez-Bertoni, Katherine J Kuhns, et al.Pageof 3